RNU7-35P

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, RNU7-35P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU7-35P data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher RNU7-35P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-35P expression acts as an unfavorable survival marker.

READ, UCEC, and COAD are the cancer types where RNU7-35P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
READOSTertileII,III,IV0.1110.919<.00199view →
UCECDFSTertileII,III,IV0.1760.736.00190view →
COADOSTertileII,III,IV0.1400.788.00227view →
LAMLDFSTertileAll0.0280.572<.00118view →
Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU7-35P–READ (OS)

Kaplan–Meier survival curve for RNU7-35P RNA-high vs -low samples in READ.

Open the READ breakdown →

Exploration